Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MLP Ventures, led by founder and CEO Brian O'Neill, is a diversified venture capital and real estate investment firm that specializes in creating large-scale platform companies within the life sciences and healthcare sectors. The company is most notable for developing The Discovery Labs, a massive 1.6 million-square-foot biotechnology and healthcare campus in King of Prussia, Pennsylvania, which serves as a hub for advanced biomanufacturing and R&D. Within this ecosystem, MLP Ventures co-founded the Center for Breakthrough Medicines (CBM), a leading contract development and manufacturing organization (CDMO) focused on cell and gene therapies. Additionally, the firm founded Recovery Centers of America (RCA), a prominent national network of addiction treatment facilities. MLP Ventures focuses on high-demand, supply-constrained products and services, positioning itself as a critical infrastructure provider for the modern biotech industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Brian O'Neill.